Myriad Genetics Inc
Score: Negative (4)
182 days at current score.
Downgraded from Neutral on February 16th 2017
- This company ranked negatively compared to the Healthcare sector despite only 1 negative IHS Markit Category
- Bearish sentiment is high
Short interest | Negative
Short interest is extremely high for MYGN with more than 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting MYGN.
ETF/Index ownership | Neutral
ETF activity is neutral. ETFs that hold MYGN had net inflows of $807 million over the last one-month.
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to email@example.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.